Exp Clin Endocrinol Diabetes 2021; 129(S 01): S70-S81
DOI: 10.1055/a-1284-6245
DDG Practice Recommendation

Diabetic Neuropathy

Dan Ziegler
1   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2   Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
Jutta Keller
3   Department of Internal Medicine, Israelite Hospital, Hamburg, Germany
,
Christoph Maier
4   Department of Pain Medicine, Ruhr University, Bochum, Germany
,
Jürgen Pannek
5   Neuro-Urology, Swiss Paraplegic Center Nottwil, Switzerland
› Author Affiliations

Note

The practice recommendation “Diabetic Neuropathy” of the DDG was developed in close alignment with the National Healthcare Guideline (Nationale Versorgungsleitlinie - NVL) “Neuropathy in Diabetes in Adulthood” (Neuropathie bei Diabetes im Erwachsenenalter), long version, version 1.2, 28 November 2011, based on the version of August 2011 [1] [2]:

German Medical Association (Bundesärztekammer - BÄK), National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung - KBV), Association of the Scientific Medical Societies (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften - AWMF). National Healthcare Guideline Adult Neuropathy in Diabetes in Adulthood - Long Version. Version 1.2, 2011 [cited: August 01, 2012]. Available at: http://www.diabetes.versorgungsleitlinien.de.([Fig. 1] [2])

Zoom Image
Fig. 1 Diagnostic criteria for diabetic sensorimotor neuropathy. Adapted from ref. 3 Source: German Medical Association (Bundesärztekammer - BÄK), National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung - KBV), Association of Scientific Medical Societies (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften - AWMF). National Healthcare Guideline Neuropathy in Diabetes in Adulthood - Long Version, 1st Edition. Version 5. 2011. Available from: www.dm-neuropathie.versorgungsleitlinien.de; DOI: 10.6101/AZQ/000 302. [rerif]
Zoom Image
Fig. 2 Algorithm for pharmacotherapy of painful diabetic sensorimotor neuropathy. Data modified according to source: German Medical Association (Bundesärztekammer - BÄK), National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung - KBV), Association of Scientific Medical Societies (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften - AWMF). National Healthcare Guideline Neuropathy in Diabetes in Adulthood - Long Version, 1st Edition. Version 5. 2011. Available from: www.dmneuropathie.versorgungsleitlinien.de; DOI: 10.6101/AZQ/000 302. [rerif]

Internet: http://www.versorgungsleitlinien.de, http://www.awmf-leitlinien.de

In June 2016 the National Healthcare Guideline was reviewed by the members of the guideline group. Until completion of the updated version (expected January 2020), several sections have been designated as “under revision” (National Healthcare Guideline Neuropathy in Diabetes in Adulthood - Long Version. 1st edition, 2011. version 5. AWMF register no.: nvl-001e. Available at: http://www.leitlinien.de/nvl/diabetes/neuropathie). Subject to revision of the National Healthcare Guideline, the sections revised in this Practice Tool reflect the position of DDG.



Publication History

Article published online:
17 August 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Haslbeck M, Redaèlli M, Parandeh-Shab F. et al. Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diabetischen Neuropathien. Scherbaum WA, Lauterbach KW, Renner R. Evidenzbasierte Diabetes-Leitlinien DDG; 1. Aufl. 2000. ISBN: 3-933740-12-6
  • 2 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung. 2011. Version 1.2 http:// www.diabetes.versorgungsleitlinien.de; http://www.awmf-leitlinien.de
  • 3 Young MJ, Boulton AJ, MacLeod AF. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
  • 4 Feldman EL, Stevens MJ, Thomas PK. et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289
  • 5 Dyck PJ, Albers JW, Andersen H. et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011; 27: 620-628
  • 6 Spallone V, Ziegler D, Freeman R. et al. Cardiovascular autonomic neuropathy in diabetes: Clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27: 639-653
  • 7 Haslbeck M, Luft D, Neundörfer B. et al. Deutsche Evidenz-basierte Diabetes-Leitlinie DDG. Diagnose und Therapie der autonomen diabetischen Neuropathien. Diabetes und Stoffwechsel 2001; 10: 113-132
  • 8 Zilliox L, Peltier AC, Wren PA. et al. Assessing autonomic dysfunction in early diabetic neuropathy: The Survey of Autonomic Symptoms. Neurology 2011; 76: 1099-1105
  • 9 Rosen RC, Cappelleri JC, Smith MD. et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Functi on (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326
  • 10 Martina ISJ, van Koningsveld R, Schmitz PIM. et al. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J Neurol Neurosurg Psychiatry 1998; 65: 743-747